KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $7.3 billion.

  • Cme's Net Cash Flow fell 4868.41% to $7.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $49.7 billion, marking a year-over-year increase of 30452.22%. This contributed to the annual value of $8.7 billion for FY2024, which is 11935.69% up from last year.
  • As of Q3 2025, Cme's Net Cash Flow stood at $7.3 billion, which was down 4868.41% from $22.0 billion recorded in Q2 2025.
  • In the past 5 years, Cme's Net Cash Flow registered a high of $36.0 billion during Q1 2021, and its lowest value of -$29.5 billion during Q2 2022.
  • Moreover, its 5-year median value for Net Cash Flow was $3.6 billion (2023), whereas its average is $3.3 billion.
  • In the last 5 years, Cme's Net Cash Flow skyrocketed by 1135696.72% in 2021 and then plummeted by 152799.2% in 2023.
  • Cme's Net Cash Flow (Quarter) stood at $10.1 billion in 2021, then tumbled by 140.82% to -$4.1 billion in 2022, then surged by 187.35% to $3.6 billion in 2023, then tumbled by 99.76% to $8.5 million in 2024, then skyrocketed by 86355.29% to $7.3 billion in 2025.
  • Its Net Cash Flow stands at $7.3 billion for Q3 2025, versus $22.0 billion for Q2 2025 and $20.3 billion for Q1 2025.